BRIEF published on 02/26/2026 at 15:35, 2 months 3 days ago Ottobock Invests in Blue Arbor Technologies for Advanced Prosthesis Control MedTech Ottobock Investment Prosthesis Control RESTORE Technology Blue Arbor
PRESS RELEASE published on 02/26/2026 at 15:30, 2 months 3 days ago Ottobock invests in future technology from Blue Arbor Technologies, Inc. Ottobock strengthens innovation with a $5 million investment in Blue Arbor Technologies, Inc.'s RESTORE implant technology for intuitive prosthesis control Investment Ottobock Prosthesis Control RESTORE Technology Blue Arbor Technologies
BRIEF published on 02/17/2026 at 07:34, 2 months 13 days ago Ottobock enregistre des résultats records et une forte croissance en 2025 Stratégie De Croissance Expansion Du Marché Prévisions Pour 2026 Résultats Financiers D'Ottobock Bionique Humaine
BRIEF published on 02/17/2026 at 07:34, 2 months 13 days ago Ottobock Achieves Record Results with Strong Growth in 2025 Growth Strategy Market Expansion Human Bionics 2026 Forecast Ottobock Financial Results
PRESS RELEASE published on 02/17/2026 at 07:29, 2 months 13 days ago Record results for Ottobock: Double-digit growth, strong profit growth, positive outlook Ottobock SE & Co. KGaA achieved record results in 2025 with double-digit growth in core revenue and strong profit growth, maintaining a positive outlook for 2026 Outlook Double-digit Growth Record Results Profit Growth Ottobock
BRIEF published on 11/13/2025 at 07:34, 5 months 17 days ago Ottobock prévoit une forte croissance de son chiffre d'affaires et de sa rentabilité sur les 9 premiers mois de l'année 2025. Croissance Financière Marge D'EBITDA Ottobock Prévisions Pour 2025 Lancement De Produits
BRIEF published on 11/13/2025 at 07:34, 5 months 17 days ago Ottobock Sees Strong Growth in Revenue and Profitability in 9M 2025 EBITDA Margin Product Launches Financial Growth Ottobock 2025 Forecast
PRESS RELEASE published on 11/13/2025 at 07:29, 5 months 17 days ago Ottobock generates strong revenue growth and increases profitability in 9M 2025 Ottobock achieves strong revenue growth and increased profitability in the first nine months of 2025. Key drivers include new product launches and strategic investments Revenue Growth Profitability MedTech Ottobock 9M 2025
BRIEF published on 10/24/2025 at 07:49, 6 months 6 days ago Ottobock renforce son investissement dans la société de neurotechnologie ONWARD® Medical Ottobock ONWARD Medical Système ARC-EX Lésion De La Moelle Épinière Investissement Dans NeuroTech
BRIEF published on 10/24/2025 at 07:49, 6 months 6 days ago Ottobock Strengthens Investment in NeuroTech Company ONWARD® Medical Ottobock ONWARD Medical ARC-EX System Spinal Cord Injury NeuroTech Investment
Published on 04/30/2026 at 08:00, 1 hour 46 minutes ago Caledonia Mining Corporation Plc: Change of Chairman
Published on 04/30/2026 at 07:15, 2 hours 31 minutes ago Route1 Reports Fiscal Year 2025 Results and Continued Transition Toward Recurring, Lifecycle-Based Revenue
Published on 04/30/2026 at 01:35, 8 hours 11 minutes ago Kalo Gold Provides Update on High-Resolution Airborne Magnetic Survey at Vatu Aurum Project, Fiji
Published on 04/30/2026 at 01:15, 8 hours 31 minutes ago Credissential Announces Shares Consolidation
Published on 04/30/2026 at 09:30, 16 minutes ago HÖRMANN Industries Publishes 2025 Annual Financial Statements
Published on 04/30/2026 at 09:05, 41 minutes ago Films on Textile Waste and Circularity as part of the "Fashion Redressed" Series
Published on 04/30/2026 at 09:02, 44 minutes ago Edison issues report on Utilico Emerging Markets Trust (UEM)
Published on 04/30/2026 at 08:00, 1 hour 46 minutes ago LDC : Augmentation de capital réservée aux salariés.
Published on 04/30/2026 at 07:45, 2 hours 1 minute ago The Belgian State and ENGIE Group enter into exclusive negotiations for the acquisition by Belgium of ENGIE's nuclear activities
Published on 04/30/2026 at 07:45, 2 hours 1 minute ago L’État belge et le groupe ENGIE entament des négociations exclusives pour l’acquisition des activités nucléaires d’ENGIE par la Belgique
Published on 04/30/2026 at 07:30, 2 hours 16 minutes ago Nieuwe Gimv Anchor investering: acquisitie van een belang van 5% in Azelis
Published on 04/30/2026 at 07:30, 2 hours 16 minutes ago New Gimv Anchor investment: acquisition of 5% shareholding in Azelis
